Source link : https://www.newshealth.biz/health-news/how-age-affects-teprotumumab-tx-in-thyroid-eye-disease/
TOPLINE: A study reveals nearly a quarter of patients treated with teprotumumab for thyroid eye disease require re-treatment within a year, and older patients are more likely to require additional treatment. METHODOLOGY: The retrospective analysis included 119 patients (mean age, 54 years; 76.5% women) from three centers in the United States who were treated with […]
Author : News Health
Publish date : 2024-07-25 09:05:45
Copyright for syndicated content belongs to the linked Source.
Categories